Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity has climbed since a decade ...

Hidradenitis suppurativa is a lesion-causing inflammatory disorder that affects at least 1 in 100 people and is strongly ...

Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity — especially women — has ...

Lawmakers are accusing the manufacturers of popular weight loss medications of price gouging U.S. consumers and the ...

"All we are saying [to Novo Nordisk] is, Treat the American people the same way that you treat people all over the world.

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today led the committee in a hearing to ...

Health-care company stocks fell as Novo Nordisk CEO Lars Fruergaard Jørgensen defended the prices of his company's megablockbuster obesity and Type 2 diabetes medicines under tough questioning on ...

Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs.

According to new numbers from a 2021 survey conducted through 2023, the obesity rate in the U.S. stands at 40%, a slight ...

The general rate of obesity among adults in the United States has stagnated, but the rate of severe obesity has increased, according to the Centers for Disease Control and Prevention.

Researchers at the University of Michigan have investigated another potential way GLP1RA drugs can be useful in treating type ...

A new CDC report says severe obesity is becoming more common in the U.S. Nearly 1 in 10 adults have severe obesity, and women ...